Drug Information Association
This article was originally published in The Tan Sheet
Will hold May 24-25 meeting titled "Nonprescription Drug Development: The Evolving Global Environment" at the Sheraton Society Hill in Philadelphia. Sessions will focus on clinical perspectives for OTCs, "self-medication in the global marketplace" and the "evolution of regulation" of OTCs globally.
You may also be interested in...
Perrigo promotes in pricing, planning
Combe sells most of its OTC brands
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC